Group 1 - Vaccine-related stocks have shown strong performance, with Zhifei Biological rising over 16%, Watson Bio increasing by more than 11%, and Kangtai Biological up by over 8% [1] - The vaccine-related ETFs have also experienced a rise of approximately 4% [1] Group 2 - Specific ETF performance includes: - Vaccine ETF from Fuguo at 0.727, up by 0.029 (4.15%) - Vaccine ETF from Penghua at 0.705, up by 0.028 (4.14%) - General Vaccine ETF at 0.642, up by 0.023 (3.72%) [2] - Institutions indicate that the long-term growth potential for vaccine demand is significant due to increasing vaccination penetration and an aging population [2] - The acceleration of approval and market entry for innovative domestic vaccines, along with increased investment in vaccine research and supportive policies, is expected to drive rapid development in China's vaccine industry [2]
疫苗概念股走强 疫苗相关ETF涨约4%
Mei Ri Jing Ji Xin Wen·2026-01-26 06:28